opko.jpg
OPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders
May 07, 2021 13:34 ET | OPKO Health, Inc.
MIAMI, May 07, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) has entered into exchange agreements with certain noteholders of the Company’s 4.50% Convertible Senior Notes due 2025...
opko.jpg
OPKO Health Reports 2021 First Quarter Business Highlights and Financial Results
April 28, 2021 16:05 ET | OPKO Health, Inc.
MIAMI, April 28, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2021. Business Highlights ...
opko.jpg
OPKO Health to Report First Quarter 2021 Financial Results on April 28, 2021
April 22, 2021 08:00 ET | OPKO Health, Inc.
MIAMI, April 22, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2021, as well as discuss financial...
opko.jpg
OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results
February 18, 2021 16:05 ET | OPKO Health, Inc.
MIAMI, Feb. 18, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2020. Business Highlights ...
opko.jpg
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021
February 03, 2021 09:01 ET | OPKO Health, Inc.
MIAMI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2020, as well as discuss financial...
opko.jpg
New Drug Application Submitted to PMDA in Japan for Somatrogon, to Treat Pediatric Patients with Growth Hormone Deficiency
January 28, 2021 08:00 ET | OPKO Health, Inc.
MIAMI, Jan. 28, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announced today that its partner, Pfizer Japan Inc., submitted a New Drug Application (NDA) to the Ministry of Health,...
opko.jpg
OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference
January 05, 2021 08:00 ET | OPKO Health, Inc.
MIAMI, Jan. 05, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 39th Annual J.P. Morgan Healthcare Conference being held...
opko.jpg
OPKO Health Appoints Dr. Roger Medel to its Board of Directors
December 21, 2020 08:00 ET | OPKO Health, Inc.
MIAMI, Dec. 21, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced the appointment of Roger Medel, M.D. as an independent member of its Board of Directors, effective December...
opko.jpg
OPKO Health to Participate in Three Upcoming Investment Conferences
November 11, 2020 09:11 ET | OPKO Health, Inc.
MIAMI, Nov. 11, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in three upcoming virtual investor conferences. H.C. Wainwright 6th...
opko.jpg
OPKO Health Reports 2020 Third Quarter Business Highlights and Financial Results
October 29, 2020 16:05 ET | OPKO Health, Inc.
MIAMI, Oct. 29, 2020 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended September 30, 2020. Third Quarter Business...